JOT Automation sells unit to Ginolis

JOT’s Life Science Division will be merged into Gilonis during the first half of 2015. “The transaction is a win-win for both companies’ customers. It enables us to grow even more customer-centric and accelerates our time-to-market in our core business,” said Mika Kettula, CEO at JOT Automation. Teijo Fabritius, CEO at Ginolis said: “Our vision is to provide more effective healthcare for the benefit of patients globally by introducing unique solutions to the diagnostic, life science and medtech industries. Our approach is similar to the one adopted in the electronics industry, known for tremendous productivity. In connection with the transaction, JOT Automation’s ownership of Ginolis will increase. This will also result in closer cooperation between the companies.